Viewing Study NCT06302660



Ignite Creation Date: 2024-05-06 @ 8:14 PM
Last Modification Date: 2024-10-26 @ 3:23 PM
Study NCT ID: NCT06302660
Status: RECRUITING
Last Update Posted: 2024-04-18
First Post: 2024-03-04

Brief Title: Profiling Microbiome Associated Metabolic Pathways in Oesophageal Cancer Survivors
Sponsor: Imperial College London
Organization: Imperial College London

Study Overview

Official Title: Profiling Microbiome Associated Metabolic Pathways in Oesophageal Cancer Survivors
Status: RECRUITING
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MAPLES
Brief Summary: The goal of this observational study is to learn about long term symptoms in oesophageal cancer survivors The main question it aims to answer is are

Study the changes in gut bacteria by examining saliva stool and blood
Investigate the products of bacteria in breath to develop a non-invasive breath test to detect the changes in gut bacteria
Develop new strategies to treat this change and trial new treatments to improve quality- of-life in oesophageal cancer survivors

Participants will attend an outpatient clinic fasted for at least 4 hours for collection of breath saliva blood urine stool and complete validated healthy-related quality-of-life questionnaires

Researchers will compare symptomatic and asymptomatic participants to detect the changes stated above
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None